Concepedia
1
Publications
16
Citations
H-Index
2019
Active since
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)
J Adedokun is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).
Publications per year
2019–2019
Early Dose Optimisation of Golimumab in Nonresponders to Induction Treatment for Ulcerative Colitis Is Effective and Supported by Pharmacokinetic Data
George Philip, Freddy Cornillie, J Adedokun et al. · Journal of Crohn s and Colitis · 2019 · 16 citations
Rows per page
1–1 of 1